期刊文献+

RP-HPLC法测定WF-208原料药有关物质

RP-HPLC determination of related substances in WF-208
原文传递
导出
摘要 目的:建立测定噁二唑基哌嗪衍生物(WF-208)原料药有关物质的RP-HPLC方法,以控制其质量。方法:采用Dia-monsil C18色谱柱(250 mm×4.6 mm,5μm);流动相:乙腈-甲醇-水,梯度洗脱;流速:1.0 mL.min-1;检测波长:238 nm;柱温:30℃。结果:WF-208能与合成过程中的2个主要中间体Ⅰ、Ⅱ和其他有关物质实现良好的分离,2个主要中间体Ⅰ、Ⅱ均在0.02~1.5 mg.L-1范围内呈良好的线性关系,检测限均为5μg.L-1。结论:本法灵敏,专属性强,可用于WF-208原料药的质量控制。 Objective : To establish an RP - HPLC method for the determination of related substances in WF - 208 ( derivative of oxadiazole piperazine). Methods: Diamonsil ClS ( 250 mm× 4. 6 mm, 5 μm) was adopted with acetonitrile - methanol - water as the mobile phase at the flow rate of 1.0 mL .min^-1, the wavelength was set at 238 nm and the column temperature was 30 ℃. Results : The two main intermediates of WF - 208 and other relat- ed substances were completely separated from WF - 208. The linearity of two main intermediates was in the range of 0. 02 - 1.5 mg. L^-1. The limit of determination (LOD) was 5 μg . L^- 1 Conclusion: The method is sensitive, specific and suitable for the separation and determination of related substances in WF -208.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第7期1205-1208,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 反相高效液相色谱法 衍生物 噁二唑基哌嗪 杂质分析WF-208 中间体 原料药 抗癌药 酶活化剂 质量控制 有关物质 RP - HPLC derivative oxadiazole piperazine impurity analysis WF - 208 intermediate crude drug anticancer drugs enzyme activator quality control related substances
  • 相关文献

参考文献3

二级参考文献24

  • 1陈钧,高小玲,江文明,蒋新国.苯甲酸利扎曲普坦含量及有关物质的HPLC测定[J].中国医药工业杂志,2004,35(10):613-614. 被引量:3
  • 2马瑾瑜,顾映红,余竹元.用快速比色计量法测量细胞生长[J].上海医科大学学报,1993,20(4):309-311. 被引量:34
  • 3阎平,冯翠玲,谢剑炜.苯甲酸利扎曲普坦的高效液相色谱分析方法研究[J].中国新药杂志,2005,14(5):585-587. 被引量:2
  • 4辛正洪,宋梦薇.高效液相色谱法测定苯甲酸利扎曲普坦的含量[J].中国新药杂志,2005,14(8):1031-1033. 被引量:3
  • 5宫平,赵燕芳.5-羟基吲哚-3-羧酸酯类衍生物及其用途:中国,1706827A,200510054663.2[P].2005-12-14.
  • 6Raj TJS,Bharathi C,Kumar MS,et al.Identification,isolation and characterization of process-related impurities in rizatriptan benzoate.J Pharm Biomed Anal, 2009,49(1):156.
  • 7Ze c[DD(-1]ˇ[DD)]evi c[DD(-1]'[DD)] M,Joci c[DD(-1]'[DD)] B,ivanovi c[DD(-1]'[DD)] L,et al.Application of multicriteria methodology in the development of improved RP-LC-DAD for determination of rizatriptan and its degradation products.Chromatographia, 2008,68(11/12):911.
  • 8Rao BM,Sangaraju S,Srinivasu MK,et al.Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.J Pharm Biomed Anal,2006,41(4):1146.
  • 9PA/PH/Exp.P4/T(09) 11 ANP.
  • 10Beers MH,Berkow R,Bogin RM,et al.The Merck Manual of Diagnosis and Therapy(默克诊疗手册).17th Ed(第十七版).Beijing(北京):People's Medical Publishing House(人民卫生出版社),2006.1620.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部